Medistim ASA (STO:MEDIO)

Market Cap	3.29B
Revenue (ttm)	576.25M
Net Income (ttm)	117.25M
Shares Out	n/a
EPS (ttm)	6.40
PE Ratio	28.05
Forward PE	26.22
Dividend	n/a
Ex-Dividend Date	n/a

Volume	150
Average Volume	555
Open	209.00
Previous Close	207.00
Day's Range	209.00 - 209.00
52-Week Range	131.00 - 210.00
Beta	n/a
RSI	66.01
Earnings Date	Aug 20, 2025

About Medistim ASA

Medistim ASA develops, produces, services, leases, and distributes medical devices for cardiac and vascular surgery in the United States, Asia, Europe, and internationally. The company offers MiraQ Cardiac, a system that combines ultrasound imaging and transit time flow measurement (TTFM) in a single system for cardiac surgery; MiraQ Vascular, a system that combines ultrasound imaging and TTFM in a single system for vascular surgery; MiraQ Ultimate that combines TTFM and ultrasound imaging in a single system for cardiac, vascular, and transplan...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 1984
• Employees: 154
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: MEDIO

Financial Performance

In 2024, Medistim ASA's revenue was 556.16 million, an increase of 6.73% compared to the previous year's 521.11 million. Earnings were 103.83 million, an increase of 0.01%.

Financial numbers in NOK